RE:RE:RE:RE:RE:RE:ARISTOTLE is better than GRAIL to detect early cancersIf all SZLS could find was a par of very small unknown Health Clinincs making very little money with a product you all claim is better than GRAIL is dead give away. The market literally acted like nothing happened when the deal closed. Nobody in reality thinks this will work of they have anything if value except the SZLS employees. The market does not lie. Look at the SP and volume and tell me otherwise. I'm not even trying to bash I'm looking at this objectively.
A big name would swoop in and scoop SZLS up for peanuts before I could end this sentance if they really had the most accurate multi-cancer blood test. That is reality.
If you want to invest in SZLS and hold go ahead I don't want to stop you it's just looking very bad for you and I am concerned Tripp is planning another heist on shareholders soon so be careful.